Nexus BioPharma, Inc.
https://www.nexusbiopharma.com/
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Nexus BioPharma, Inc.
Novo Dips Into Money Pile Again To Boost Obesity Drug Manufacturing
The Danish drugmaker is investing over $4.1bn on a second facility in North Carolina for its GLP-1 therapies but has abandoned plans to build a new plant in Dublin, Ireland.
Lilly Commits Another $5.3bn To Tirzepatide Supply Expansion Effort
Lilly is now spending about $9bn total to bring an Indiana manufacturing site for tirzepatide to readiness, although it is not expected to supply finished product until 2026.
Company Information
- Industry
- Pharmaceuticals
- Other Names / Subsidiaries
-
- Nexus BioPharma Inc.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Nexus BioPharma, Inc.
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice